The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors
- 15 October 1991
- Vol. 68 (8) , 1803-1807
- https://doi.org/10.1002/1097-0142(19911015)68:8<1803::aid-cncr2820680826>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinomaBritish Journal of Cancer, 1990
- Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsyCancer, 1989
- Tribute to Patrick Steptoe: beginnings of laparoscopyHuman Reproduction, 1989
- Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown originEuropean Journal of Cancer and Clinical Oncology, 1988
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival durationCancer, 1988
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987
- Staging laparotomy in early epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- A critical reassessment of second-look laparotomy in epithelial ovarian carcinomaCancer, 1986
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983